BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection and Symptomatic Disease in Five-Month Follow-Up: A Retrospective Cohort Study

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection and Symptomatic Disease in Five-Month Follow-Up: A Retrospective Cohort Study

To combat the COVID-19 pandemic, a mass vaccination campaign was initiated in Italy on 27 December 2020. The vaccine available to immunize Italian healthcare workers (HCWs) was the BNT162b2 mRNA COVID-19 vaccine (Comirnaty). This study evaluated the effectiveness of the vaccine against documented SA...

Full description

Bibliographic Details
Main Authors: Francesco Paolo Bianchi, Silvio Tafuri, Giovanni Migliore, Luigi Vimercati, Andrea Martinelli, Annamaria Lobifaro, Giusy Diella, Pasquale Stefanizzi, on behalf of the Control Room Working Group
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Vaccines
Subjects:
COVID-19
documented infection
vaccine effectiveness
healthcare workers
Online Access:https://www.mdpi.com/2076-393X/9/10/1143

Internet

https://www.mdpi.com/2076-393X/9/10/1143

Similar Items